期刊文献+
共找到227篇文章
< 1 2 12 >
每页显示 20 50 100
Assessment of biological functions for C3A cells interacting with adverse environments of liver failure plasma 被引量:1
1
作者 Zu-Hong Li Zhong-Yang Xie +7 位作者 Xiao-Xi Ouyang Kai-Zhou Huang Xiao-Peng Yu Ya-Lei Zhao Yan-Hong Zhang Dan-Hua Zhu Jiong Yu Lan-Juan Li 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2020年第2期129-137,共9页
Background:For its better differentiated hepatocyte phenotype,C3A cell line has been utilized in bioar-tificial liver system.However,up to now,there are only a few of studies working at the metabolic alter-nations of ... Background:For its better differentiated hepatocyte phenotype,C3A cell line has been utilized in bioar-tificial liver system.However,up to now,there are only a few of studies working at the metabolic alter-nations of C3A cells under the culture conditions with liver failure plasma,which mainly focus on car-bohydrate metabolism,total protein synthesis and ureagenesis.In this study,we investigated the effects of acute liver failure plasma on the growth and biological functions of C3A cells,especially on CYP450 enzymes.Methods:C3A cells were treated with fresh DMEM medium containing 10%FBS,fresh DMEM medium containing 10%normal plasma and acute liver failure plasma,respectively.After incubation,the C3A cells were assessed for cell viabilities,lactate dehydrogenase leakage,gene transcription,protein levels,albu-min secretion,ammonia metabolism and CYP450 enzyme activities.Results:Cell viabilities decreased 15%,and lactate dehydrogenase leakage had 1.3-fold elevation in acute liver failure plasma group.Gene transcription exhibited up-regulation,down-regulation or stability for different hepatic genes.In contrast,protein expression levels for several CYP450 enzymes kept constant,while the CYP450 enzyme activities decreased or remained stable.Albumin secretion reduced about 48%,and ammonia accumulation increased approximately 41%.Conclusions:C3A cells cultured with acute liver failure plasma showed mild inhibition of cell viabilities,reduction of albumin secretion,and increase of ammonia accumulation.Furthermore,CYP450 enzymes demonstrated various alterations on gene transcription,protein expression and enzyme activities. 展开更多
关键词 C3A cells Acute liver failure Biological function CYP450 ENZYMES
下载PDF
Preoperative Evaluation of Posthepatectomy Liver Failure Using MRI-Based Liver Function Indices in Child-Pugh Class A Patient
2
作者 Shigeru Matsushima Yozo Sato +7 位作者 Hidekazu Yamaura Mina Kato Yui Onoda Shinichi Murata Yasuhiro Shimizu Yasutomi Kinosada Hideyuki Nishiofuku Yoshitaka Inaba 《Open Journal of Radiology》 2016年第2期147-156,共10页
Purpose: To evaluate posthepatectomy liver failure (PHLF) using gadoxetic acid-enhanced magnetic resonance imaging (MRI) with a measure of relative liver enhancement (RLE) on hepatobiliary phase images, thereby facili... Purpose: To evaluate posthepatectomy liver failure (PHLF) using gadoxetic acid-enhanced magnetic resonance imaging (MRI) with a measure of relative liver enhancement (RLE) on hepatobiliary phase images, thereby facilitating safe liver resection. Methods: Twenty patients in Child-Pugh class A underwent tumor excision surgery and indocyanine green (ICG) clearance of future remnant liver (FRL) (ICG-Krem) values were >0.05. PHLF was evaluated using the grading system of the International Study Group of Liver Surgery (ISGLS). The RLE value was defined as the signal gain percentage between the precontrast and hepatocellular images. In the whole liver and FRL, theRLE value measured the tumor-free liver parenchyma in RLE images. We examined the correlation between indocyanine green clearance (ICG-K) and MRI-based liver function in the whole liver. Preoperative PHLF evaluation was predicted using remnant hepatocellular uptake index (rHUI), remnant RLE (rRLE), coefficient variation of Rrle [Cv(rRLE)], and ICG-Krem corrected by heterogeneous liver function(HLF-ICG-Krem). Results: HLF-ICG-Krem and rRLE values correlated with INRs after postoperative day five (r = -0.55 and 0.46, p = 0.01 and 0.04, respectively). Furthermore, HLF-ICG-Krem values ≤0.05 detected two patients with higher INRs after postoperative day five. On the other hand, neither rHUI nor Cv(rRLE) was correlated with INRs after postoperative day five (r = 0.28, and -0.03, respectively;p >0.05 for both). HLF-ICG-Krem was significantly lower with PHLF than without PHLF (p = 0.005). Conclusion: HLF-ICG-Krem is useful for evaluating PHLF more correctly. 展开更多
关键词 Posthepatectomy liver failure Heterogeneous liver function Gadoxetic Acid Relative liver Enhancement Indocyanine Green Clearance
下载PDF
Delayed diagnosis of alpha-1-antitrypsin deficiency following post-hepatectomy liver failure: A case report 被引量:3
3
作者 Benjamin Norton Jemimah Denson +3 位作者 Christopher Briggs Matthew Bowles David Stell Somaiah Aroori 《World Journal of Gastroenterology》 SCIE CAS 2016年第11期3289-3295,共7页
Post-hepatectomy liver failure(PHLF) is a leading cause of morbidity and mortality following major liver resection. The development of PHLF is dependent on the volume of the remaining liver tissue and hepatocyte funct... Post-hepatectomy liver failure(PHLF) is a leading cause of morbidity and mortality following major liver resection. The development of PHLF is dependent on the volume of the remaining liver tissue and hepatocyte function. Without effective pre-operative assessment, patients with undiagnosed liver disease could be at increased risk of PHLF. We report a case of a 60-year-old male patient with PHLF secondary to undiagnosed alpha-1-antitrypsin deficiency(AATD) following major liver resection. He initially presented with acute large bowel obstruction secondary to a colorectal adenocarcinoma, which had metastasized to the liver. There was no significant past medical history apart from mild chronic obstructive pulmonary disease. After colonic surgery and liver directed neo-adjuvant chemotherapy, he underwent a laparoscopic partially extended right hepatectomy and radio-frequency ablation. Post-operatively he developed PHLF. The cause of PHLF remained unknown, prompting reanalysis of the histology, which showed evidence of AATD. He subsequently developed progressive liver dysfunction, portal hypertension, and eventually an extensive parastomal bleed, which led to his death; this was ultimately due to a combination of AATD and chemotherapy. This case highlights that formal testing for AATD in all patients with a known history of chronic obstructive pulmonary disease, heavy smoking, or strong family history could help prevent the development of PHLF in patients undergoing major liver resection. 展开更多
关键词 Post-hepatectomy liver failure Alpha-1-antitrypsin DEFICIENCY HEPATECTOMY functional liver remnant L
下载PDF
Pre-hepatectomy type Ⅳ collagen 7S predicts post-hepatectomy liver failure and recovery 被引量:4
4
作者 Masatsugu Ishii Osamu Itano +8 位作者 Masahiro Shinoda Minoru Kitago Yuta Abe Taizo Hibi Hiroshi Yagi Ayano Takeuchi Hanako Tsujikawa Tokiya Abe Yuko Kitagawa 《World Journal of Gastroenterology》 SCIE CAS 2020年第7期725-739,共15页
BACKGROUND Liver resection is an effective treatment for benign and malignant liver tumors.However,a method for preoperative evaluation of hepatic reserve has not yet been established.Previously reported assessments o... BACKGROUND Liver resection is an effective treatment for benign and malignant liver tumors.However,a method for preoperative evaluation of hepatic reserve has not yet been established.Previously reported assessments of preoperative hepatic reserve focused only on liver failure in the early postoperative period and did not consider the long-term recovery of hepatic reserve.When determining eligibility for hepatectomy,the underlying pathophysiology needs to be considered to determine if the functional hepatic reserve can withstand both surgery and any postoperative therapy.AIM To identify pre-hepatectomy factors associated with both early postoperative liver failure and long-term postoperative liver function recovery.METHODS This study was a retrospective cohort study.We retrospectively investigated 215 patients who underwent hepatectomy at our hospital between May 2013 and December 2016.Early post-hepatectomy liver failure(PHLF)was defined using the International Study Group of Liver Surgery’s definition of PHLF.Long-term postoperative recovery of liver function was defined as the time taken for serum total bilirubin and albumin levels to return to levels of<2 mg/dL and>2.8 g/dL,respectively,and the time taken for Child-Pugh score to return to Child-Pugh class A.RESULTS Preoperative type IV collagen 7S was identified as a significant independent factor associated with both PHLF and postoperative long-term recovery of liver function.Further analysis revealed that the time taken for the recovery of Child-Pugh scores and serum total bilirubin and albumin levels was significantly shorter in patients with type IV collagen 7S≤6 ng/mL than in those with type IV collagen 7S>6 ng/mL.In additional analyses,similar results were observed in patients without chronic viral hepatitis associated with fibrosis.CONCLUSION Preoperative type IV collagen 7S is a preoperative predictor of PHLF and longterm postoperative liver function recovery.It can also be used in patients without chronic hepatitis virus. 展开更多
关键词 HEPATECTOMY liver failure Type IV collagen 7S liver fibrosis Postoperative complications Long-term postoperative liver function recovery
下载PDF
间充质干细胞来源外泌体治疗动物急性肝衰竭的Meta分析 被引量:1
5
作者 马树微 何生 +1 位作者 韩冰 张缭云 《中国组织工程研究》 CAS 北大核心 2024年第7期1137-1142,共6页
目的:评价间充质干细胞来源外泌体治疗急性肝衰竭动物模型的效果。方法:检索PubMed、Web of Science、Embase、The Cochrane Library、CBM、CNKI、万方、维普数据库,收集各数据库建库至2023-01-16期间有关间充质干细胞外泌体治疗急性肝... 目的:评价间充质干细胞来源外泌体治疗急性肝衰竭动物模型的效果。方法:检索PubMed、Web of Science、Embase、The Cochrane Library、CBM、CNKI、万方、维普数据库,收集各数据库建库至2023-01-16期间有关间充质干细胞外泌体治疗急性肝衰竭的动物实验。由2名研究人员独立筛选文献并提取数据,应用SYRCLE工具评估偏倚风险。提取的数据由Revman 5.4.1软件和Stata 17.0软件进行分析。结果:共检索出241篇相关文献,筛选9篇动物实验纳入分析,共219只动物:模型组110只,外泌体组109只。研究结果显示外泌体组动物生存率较模型组显著提高[RR=9.34,95%CI(3.91,22.29),P<0.001],血清丙氨酸氨基转移酶水平[SMD=-5.31,95%CI(-7.43,-3.19),P<0.001]及天门冬氨酸氨基转移酶水平[SMD=-4.47,95%CI(-5.85,-3.10),P<0.001]明显降低,白细胞介素1β[SMD=-11.54,95%CI(-18.12,-4.95),P=0.0006]、白细胞介素6[SMD=-5.75,95%CI(-8.08,-3.41),P<0.001]、肿瘤坏死因子α[SMD=-4.46,95%CI(-6.83,-2.09),P=0.0002]等促炎因子的表达水平明显降低。结论:间充质干细胞外泌体有助于抑制炎症反应,改善急性肝衰竭动物的肝功能,并提高其生存率。亚组分析结果提示,动物生存时间较短(≤24 h)、外泌体移植剂量较小(<1 mg/kg)及外泌体来源(脂肪间充质干细胞)可能会影响间充质干细胞外泌体治疗急性肝衰竭动物模型的疗效。该结论及临床转化仍需大样本量、高质量的随机对照研究予以证实。 展开更多
关键词 间充质干细胞 外泌体 急性肝衰竭 动物 生存率 肝功能 系统评价 META分析
下载PDF
低置换量血浆置换术联合双重血浆分子吸附术治疗慢加急性肝衰竭患者短期预后的结果
6
作者 邹波 朱龙川 +2 位作者 甘达凯 张鑫垚 姚雪兵 《实用医学杂志》 CAS 北大核心 2024年第3期348-352,359,共6页
目的探讨低置换量血浆置换术(LPE)+双重血浆分子吸附术(DPMAS)联合治疗慢加急性肝衰竭(ACLF)患者的效果,及对患者肝功能、炎症细胞因子及短期预后的影响。方法使用信封法将100例ACLF患者随机分为观察组和对照组,各50例。两组均常规予以... 目的探讨低置换量血浆置换术(LPE)+双重血浆分子吸附术(DPMAS)联合治疗慢加急性肝衰竭(ACLF)患者的效果,及对患者肝功能、炎症细胞因子及短期预后的影响。方法使用信封法将100例ACLF患者随机分为观察组和对照组,各50例。两组均常规予以护肝、退黄、降酶、抗病毒、预防出血等治疗。对照组在常规治疗基础上,予以血浆置换(PE)治疗;观察组在常规治疗基础上,予以LPE+DP⁃MAS联合治疗。比较两组患者治疗后肝功能、凝血功能、炎症细胞因子水平、不良反应发生率及90 d生存率。结果治疗后,观察组患者肝功能、凝血功能及炎症细胞因子水平均优于对照组(P<0.05)。两组患者90 d生存率和不良反应总发生率比较,差异无统计学意义(P>0.05)。结论LPE+DPMAS联合治疗ACLF患者,可有效改善肝功能及凝血功能,降低炎症因子水平,安全性高。 展开更多
关键词 低置换量血浆置换术 双重血浆分子吸附术 慢加急性肝衰竭 肝功能 炎症细胞因子
下载PDF
夜间加餐营养支持对慢加急性肝衰竭患者TIPS治疗后的影响
7
作者 徐晓萌 张盼盼 +1 位作者 宋佳 原翔 《国际医药卫生导报》 2024年第5期867-871,共5页
目的探讨夜间加餐营养支持对慢加急性肝衰竭患者经颈静脉肝内门体静脉分流术(TIPS)治疗后的肝脏储备功能、人体测量学指标及蛋白水平影响。方法前瞻性研究,选取2020年9月至2022年9月来河南科技大学第一附属医院接受治疗的107例经TIPS治... 目的探讨夜间加餐营养支持对慢加急性肝衰竭患者经颈静脉肝内门体静脉分流术(TIPS)治疗后的肝脏储备功能、人体测量学指标及蛋白水平影响。方法前瞻性研究,选取2020年9月至2022年9月来河南科技大学第一附属医院接受治疗的107例经TIPS治疗后的慢加急性肝衰竭患者作为研究对象,根据简单随机化法将其分为对照组(53例)与研究组(54例)。对照组:男42例,女11例,年龄27~69(53.15±4.79)岁,接受日间加餐营养支持治疗;研究组:男45例,女9例,年龄24~67(52.48±5.02)岁,在对照组的基础上增加夜间加餐营养支持治疗。治疗时间均为1个月,统计学方法采用t检验。结果治疗1个月后,研究组的营养风险筛查(NRS-2002)评分低于对照组[(2.43±0.47)分比(3.68±0.91)分],差异有统计学意义(t=8.90,P<0.05)。治疗1个月后,研究组的Child-Pugh评分低于对照组[(7.12±1.41)分比(8.64±1.63)分],差异有统计学意义(t=5.16,P<0.05)。治疗1个月后,研究组体质量指数(BMI)、上臂肌围(MAMC)、肱三头肌皮褶厚度(TSF)水平均高于对照组[(22.11±1.83)kg/m^(2)比(21.09±2.05)kg/m^(2)、(24.18±2.35)cm比(22.48±3.02)cm、(13.06±3.31)cm比(11.26±2.78)cm],差异均有统计学意义(t=2.71、3.25、3.05,均P<0.05)。治疗1个月后,研究组白蛋白(ALB)、前白蛋白(PA)、转铁蛋白(TRF)水平均高于对照组[(34.06±7.24)g/L比(31.26±6.71)g/L、(138.26±33.49)mg/L比(103.18±24.36)mg/L、(1887.14±241.59)mg/L比(1695.26±216.31)mg/L],差异均有统计学意义(t=2.08、6.21、4.33,均P<0.05)。结论增加夜间加餐营养支持治疗可以降低慢加急性肝衰竭患者经TIPS治疗后的营养不良发生风险,增强肝脏储备功能,改善患者的身体状况及营养状态。 展开更多
关键词 慢加急性肝衰竭 经颈静脉肝内门体静脉分流术 夜间加餐营养支持 肝脏储备功能 营养风险
下载PDF
Liver involvement in systemic infection 被引量:9
8
作者 Masami Minemura Kazuto Tajiri Yukihiro Shimizu 《World Journal of Hepatology》 CAS 2014年第9期632-642,共11页
The liver is often involved in systemic infections,resulting in various types of abnormal liver function test results.In particular,hyperbilirubinemia in the range of 2-10 mg/dL is often seen in patients with sepsis,a... The liver is often involved in systemic infections,resulting in various types of abnormal liver function test results.In particular,hyperbilirubinemia in the range of 2-10 mg/dL is often seen in patients with sepsis,and several mechanisms for this phenomenon have been proposed.In this review,we summarize how the liver is involved in various systemic infections that are not considered to be primarily hepatotropic.In most patients with systemic infections,treatment for the invading microbes is enough to normalize the liver function tests.However,some patients may show severe liver injury or fulminant hepatic failure,requiring intensive treatment of the liver. 展开更多
关键词 liver DYSfunction liver function test SYSTEMIC INFECTION IMMUNOLOGY liver failure
下载PDF
PD-1 Involvement in Peripheral Blood CD8+T Lymphocyte Dysfunction in Patients with Acute-on-chronic Liver Failure 被引量:2
9
作者 Xiaoshuang Zhou Yidong Li +4 位作者 Yaqiu Ji Tian Liu Ninghui Zhao Jiefeng He Jia Yao 《Journal of Clinical and Translational Hepatology》 SCIE 2021年第3期283-290,共8页
Background and Aims:Programmed cell death-1(PD-1)plays an important role in downregulating T lymphocytes but the mechanisms are still poorly understood.This study aimed to explore the role of PD-1 in CD8^(+)T lymphocy... Background and Aims:Programmed cell death-1(PD-1)plays an important role in downregulating T lymphocytes but the mechanisms are still poorly understood.This study aimed to explore the role of PD-1 in CD8^(+)T lymphocyte dysfunction in hepatitis B virus(HBV)-related acute-on-chronic liver failure(ACLF).Methods:Thirty patients with HBV-ACLF and 30 healthy controls(HCs)were recruited.The differences in the numbers and functions of CD8^(+)T lymphocytes,PD-1 and glucose transporter-1(Glut1)expression from the peripheral blood of patients with HBV-ACLF and HCs were analyzed.In vitro,the CD8^(+)T lymphocytes from HCs were cultured(HC group)and the CD8^(+)T lymphocytes from ACLF patients were cultured with PD-L1-IgG(ACLF+PD-1 group)or IgG(ACLF group).The numbers and functions of CD8^(+)T lymphocytes,PD-1 expression,glycogen uptake capacity,and Glut1,hexokinase-2(HK2),and pyruvate kinase(PKM2)expression were analyzed among the HC group,ACLF group and ACLF+PD-1group.Results:The absolute numbers of CD8^(+)T lymphocytes in the peripheral blood from patients with HBVACLF were lower than in the HCs(p<0.001).The expression of PD-1 in peripheral blood CD8^(+)T lymphocytes was lower in HCs than in patients with HBV-ACLF(p=0.021).Compared with HCs,PD-1 expression was increased(p=0.021)and Glut1 expression was decreased(p=0.016)in CD8^(+)T lymphocytes from the HBV-ACLF group.In vitro,glycogen uptake and functions of ACLF CD8^(+)T lymphocytes were significantly lower than that in HCs(p=0.017;all p<0.001).When PD-1/PD-L1 was activated,the glycogen uptake rate and expression levels of Glut1,HK2,and PKM2 showed a decreasing trend(ACLF+PD-1 group compared to ACLF group,all p<0.05).The functions of CD8^(+)T lymphocytes in the ACLF+PD-1 group[using biomarkers of Ki67,CD69,IL-2,interferon-gamma,and tumor necrosis factor-alpha-were lower than in the ACLF group(all p<0.05).Conclusions:CD8^(+)T lymphocyte dysfunction is observed in patients with HBV-ACLF.PD-1-induced T lymphocyte dysfunction might involve glycolysis inhibition. 展开更多
关键词 Acute and chronic liver failure Programmed cell death 1 Immune function GLYCOLYSIS GLUT1
原文传递
Predictive factors of short term outcome after liver transplantation: A review 被引量:5
10
作者 Giuliano Bolondi Federico Mocchegiani +3 位作者 Roberto Montalti Daniele Nicolini Marco Vivarelli Lesley De Pietri 《World Journal of Gastroenterology》 SCIE CAS 2016年第26期5936-5949,共14页
Liver transplantation represents a fundamental therapeutic solution to end-stage liver disease. The need for liver allografts has extended the set of criteria for organ acceptability, increasing the risk of adverse ou... Liver transplantation represents a fundamental therapeutic solution to end-stage liver disease. The need for liver allografts has extended the set of criteria for organ acceptability, increasing the risk of adverse outcomes. Little is known about the early postoperative parameters that can be used as valid predictive indices for early graft function, retransplantation or surgical reintervention, secondary complications, long intensive care unit stay or death. In this review, we present state-of-the-art knowledge regarding the early posttransplantation tests and scores that can be applied during the first postoperative week to predict liver allograft function and patient outcome, thereby guiding the therapeutic and surgical decisions of the medical staff. Post-transplant clinical and biochemical assessment of patients through laboratory tests(platelet count, transaminase and bilirubin levels, INR, factor V, lactates, and Insulin Growth Factor 1) and scores(model for end-stage liver disease, acute physiology and chronic health evaluation, sequential organ failure assessment and model of early allograft function have been reported to have good performance, but they only allow late evaluation of patient status and graft function, requiring days to be quantified. The indocyanine green plasma disappearance rate has long been used as a liver function assessment technique and has produced interesting, although not univocal, results when performed between the 1th and the 5th day after transplantation. The liver maximal function capacity test is a promising method of metabolic liver activity assessment, but its use is limited by economic cost and extrahepatic factors. To date, a consensual definition of early allograft dysfunction and the integration and validation of the above-mentioned techniques, through the development of numerically consistent multicentric prospective randomised trials, are necessary. The medical and surgical management of transplanted patients could be greatly improved by using clinically reliable tools to predict early graft function. 展开更多
关键词 liver TRANSPLANT liver failure Early ALLOGRAFT DYSfunction Primary non-function Initial POOR functio
下载PDF
Scoring criteria for determining the safety of liver resection for malignant liver tumors
11
作者 Kohei Harada Minoru Nagayama +9 位作者 Yoshiya Ohashi Ayaka Chiba Kanako Numasawa Makoto Meguro Yasutoshi Kimura Hiroshi Yamaguchi Masahiro Kobayashi Koji Miyanishi Junji Kato Toru Mizuguchi 《World Journal of Meta-Analysis》 2019年第5期234-248,共15页
BACKGROUND Liver resection has become safer as it has become less invasive.However,the minimum residual liver volume(RLV)required to maintain homeostasis is unclear.Furthermore,the formulae used to calculate standard ... BACKGROUND Liver resection has become safer as it has become less invasive.However,the minimum residual liver volume(RLV)required to maintain homeostasis is unclear.Furthermore,the formulae used to calculate standard liver volume(SLV)are complex.AIM To review previously reported SLV formulae and the methods used to evaluate the minimum RLV,and explore the association between liver volume and mortality.METHODS A systematic review of Medline,PubMed,and grey literature was performed.References in the retrieved articles were cross-checked manually to obtain further studies.The last search was conducted on January 20,2019.We developed an SLV formula using data for 86 consecutive patients who underwent hepatectomy at our institution between July 2009 and August 2011.RESULTS Linear regression analysis revealed the following formula:SLV(mL)=822.7×body surface area(BSA)?183.2(R2=0.419 and R=0.644,P<0.001).We retrieved 25 studies relating to SLV formulae and 12 studies about the RLV required for safe liver resection.Although the previously reported formulae included various coefficient and constant values,a simplified version of the SLV,the common SLV(cSLV),can be calculated as follows:cSLV(mL)=710 or 770×BSA.The minimum RLV for normal and damaged livers ranged from 20%-40%and 30%-50%,respectively.The Sapporo score indicated that the minimum RLV ranges from 35%-95%depending on liver function.CONCLUSION We reviewed SLV formulae and the minimum RLV required for safe liver resection.The Sapporo score is the only liver function-based method for determining the minimum RLV. 展开更多
关键词 Standard liver VOLUME RESIDUAL liver VOLUME HEPATECTOMY MORTALITY liver failure liver function
下载PDF
DPMAS联合PE治疗肝衰竭的临床效果观察 被引量:1
12
作者 杨航 罗永燕 +2 位作者 潘璐达 张略韬 宋素娜 《肝脏》 2023年第6期707-710,739,共5页
目的研究双重血浆分子吸附系统(DPMAS)联合血浆置换(PE)治疗肝衰竭的效果。方法纳入广东省人民医院2018年10月至2022年5月收治的138例肝衰竭患者,根据随机、对照、双盲原则,以随机数字表法将患者分为A、B、C 3组,每组46例。A组行DPMAS治... 目的研究双重血浆分子吸附系统(DPMAS)联合血浆置换(PE)治疗肝衰竭的效果。方法纳入广东省人民医院2018年10月至2022年5月收治的138例肝衰竭患者,根据随机、对照、双盲原则,以随机数字表法将患者分为A、B、C 3组,每组46例。A组行DPMAS治疗,B组行PE治疗,C组行DPMAS序贯PE治疗。记录3组治疗效果。检测3组患者肝功能指标(AST、ALT、TBil)、血清细胞因子(TNF-α、IFN-γ及IL-6)及凝血功能指标(PT、INR、PTA)水平变化情况。结果治疗第90天时C组显效22例,有效14例,无效3例,死亡7例;显著优于A组(显效12例,有效19例,无效3例,死亡12例)和B组(显效11例,有效18例,无效3例,死亡14例)(Z=-2.044、-2.408,P=0.041、0.016)。B组治疗第28天、第90天时TBil为(201.1±77.4)μmol/L和(93.6±28.2)μmol/L,显著高于A组的(157.9±56.2)μmol/L和(80.2±21.7)μmol/L和C组的(162.7±50.2)μmol/L和(78.6±24.6)μmol/L(F=6.630、5.004,P=0.002、0.008)。C组治疗第90天时血清TNF-α、IFN-γ及IL-6分别为(20.6±14.4)pg/mL、(32.4±13.8)pg/mL及(31.7±10.1)ng/L,显著低于A组的(34.2±16.2)pg/mL、(43.2±18.4)pg/mL及(48.7±14.4)ng/L和B组的(35.7±17.3)pg/mL、(40.6±17.6)pg/mL及(50.0±12.8)ng/L(F=12.417、5.228、30.406,P<0.01、0.007、<0.01)。治疗第90天时A组PT和INR分别为(18.3±3.8)s和(1.23±0.11),显著高于B组的(15.1±3.6)s和(1.10±0.09)、C组的(14.6±3.9)s和(1.07±0.27),(F=13.052、10.722,均P<0.01)。结论DPMAS序贯PE治疗方案用于肝衰竭患者,能发挥DPMAS和PE各自优势,清除细胞因子,改善凝血紊乱状态,保护肝功能,提高疗效。 展开更多
关键词 肝衰竭 双重血浆分子吸附系统 血浆置换 细胞因子 肝功能
下载PDF
甘露消毒丹联合退黄汤治疗慢加急性肝衰竭湿热蕴结证患者的临床观察 被引量:3
13
作者 丁晓娟 邹晓华 张红梅 《湖南中医药大学学报》 CAS 2023年第6期1049-1053,共5页
目的探讨甘露消毒丹联合退黄汤治疗慢加急性肝衰竭湿热蕴结证患者的临床疗效。方法选择安徽中医药大学第一附属医院就诊的慢加急性肝衰竭患者74例,根据随机数字表法分为对照组与观察组,各37例,两组均给予西药常规治疗,对照组患者给予退... 目的探讨甘露消毒丹联合退黄汤治疗慢加急性肝衰竭湿热蕴结证患者的临床疗效。方法选择安徽中医药大学第一附属医院就诊的慢加急性肝衰竭患者74例,根据随机数字表法分为对照组与观察组,各37例,两组均给予西药常规治疗,对照组患者给予退黄汤灌肠治疗,观察组在对照组基础上给予甘露消毒丹口服治疗,水煎服400 mL,日1剂,分早晚2次,饭后温服各200 mL,连续治疗8周。观察两组治疗前后临床疗效;进行中医证候评分;检测丙氨酸氨基转移酶(alanine aminotransferase,ALT)、天冬氨酸氨基转移酶(aspartate aminotransferase,AST)、白蛋白(albumin,ALB)以及总胆红素(total bilirubin,TBIL)评价肝功能;检测凝血酶原时间(prothrombin time,PT)、凝血酶原活动度(prothrombin time activity,PTA)评价凝血功能;腹部彩超检查肝右叶厚度、门静脉内径和胆囊壁厚度。结果治疗后观察组总有效率91.89%,显著高于对照组的70.27%(P<0.05)。治疗后两组中医证候评分均较治疗前降低,且观察组低于对照组(P<0.05)。治疗后两组ALT、AST、TBIL指标均较治疗前降低,ALB较治疗前升高,且观察组优于对照组(P<0.05)。治疗后两组PT指标均较治疗前降低,两组PTA指标均较治疗前升高,且观察组优于对照组(P<0.05)。治疗后两组门静脉内径、胆囊壁厚度均较治疗前降低,肝右叶厚度较治疗前升高,且观察组优于对照组(P<0.05)。结论甘露消毒丹联合退黄汤治疗慢加急性肝衰竭患者具有一定临床疗效。 展开更多
关键词 甘露消毒丹 退黄汤 慢加急性肝衰竭 湿热蕴结证 肝功能 凝血功能
下载PDF
肝切除术前肝储备功能的评估方法 被引量:1
14
作者 裴俊鹏 丁佑铭 《临床肝胆病杂志》 CAS 北大核心 2023年第5期1219-1226,共8页
目前肝切除术已成为绝大多数肝胆良恶性病变的首选治疗方式。肝功能衰竭是肝切除术后的常见并发症,对于恶性疾病,如何最大程度清除病灶并降低术后肝功能衰竭发生率,是目前肝切除术面对的重点问题。术前对肝脏储备功能正确、充分的评估,... 目前肝切除术已成为绝大多数肝胆良恶性病变的首选治疗方式。肝功能衰竭是肝切除术后的常见并发症,对于恶性疾病,如何最大程度清除病灶并降低术后肝功能衰竭发生率,是目前肝切除术面对的重点问题。术前对肝脏储备功能正确、充分的评估,可以为肝脏疾病进展、治疗效果及预后提供判断依据。目前,对肝脏储备功能及手术可行性的评估方法繁多,各有其优缺点,尚无单一全面性的评估方法,对目前常用评估方法的特点及进展进行综述。 展开更多
关键词 肝切除术 肝功能衰竭 肝脏功能储备 术前评估
下载PDF
CT全灌注成像在肝癌患者肝动脉化疗栓塞介入术前肝储备功能评估中的应用 被引量:1
15
作者 贾晨星 《黑龙江医学》 2023年第10期1167-1169,共3页
目的:探讨肝癌患者肝动脉化疗栓塞(TACE)介入术前CT全灌注成像对其肝储备功能的评估价值,以便为临床准确评估患者肝储备功能提供指导和参考。方法:选取2020年1月-2021年1月郑州市第三人民医院收治的74例肝癌患者作为研究对象。所有患者... 目的:探讨肝癌患者肝动脉化疗栓塞(TACE)介入术前CT全灌注成像对其肝储备功能的评估价值,以便为临床准确评估患者肝储备功能提供指导和参考。方法:选取2020年1月-2021年1月郑州市第三人民医院收治的74例肝癌患者作为研究对象。所有患者均接受CT全灌注成像,分析比较不同肝组织及肝功能分级患者的灌注参数,及灌注参数与肝功能分级的相关性。结果:与正常肝组织相比,肿瘤组织肝动脉灌注(HAP)、肝动脉灌注指数(HAPI)指标较高,而门静脉灌注量(PVP)及总肝灌注量(TLP)指标较低,两组患者各项指标比较,差异有统计学意义(t=6.606、27.813、17.130、57.440,P<0.05);与B级患者相比A级患者的PVP、TLP指标较高,而HAPI指标较低且两组灌注参数比较,差异有统计学意义(t=1.761、12.329、9.837、3.583,P<0.05);HAPI与Child-Pugh分级呈正相关性,PVP、TLP与Child-Pugh分级呈负相关性(r=0.440、-0.549、-0.487,P<0.05)。结论:在肝癌患者TACE术前采用CT全灌注成像检测能够对肝癌瘤体的血液供应特点与灌注情况获得准确反映,有效评估其肝储备功能,同时,灌注参数与Child-Pugh分级存在较好的相关性,有利于治疗方案的针对性实施。 展开更多
关键词 肝癌 肝动脉化疗栓塞介入术 CT灌注成像 肝储备功能 肝功能衰竭 相关性
下载PDF
甲泼尼龙联合抗病毒药物治疗对乙型肝炎早期肝衰竭患者肝功能及炎性因子的影响
16
作者 张雄乐 陈芬兰 林文 《中国医药指南》 2023年第34期98-101,共4页
目的 分析甲泼尼龙联合抗病毒药物治疗对乙型肝炎早期肝衰竭患者肝功能及炎性因子的影响。方法 选取80例乙型肝炎早期肝衰竭患者,均为我院2020年1月至2022年12月所收治,按照入院先后顺序将其分为对照组(40例)与研究组(40例),其中对照组... 目的 分析甲泼尼龙联合抗病毒药物治疗对乙型肝炎早期肝衰竭患者肝功能及炎性因子的影响。方法 选取80例乙型肝炎早期肝衰竭患者,均为我院2020年1月至2022年12月所收治,按照入院先后顺序将其分为对照组(40例)与研究组(40例),其中对照组仅接受恩替卡韦治疗,研究组则接受甲泼尼龙联合恩替卡韦治疗,运用SPSS 21.0软件比较两组的临床疗效、实验室主要检查指标、终末期肝病模型(MELD)评分、炎性因子及药物不良反应。结果 相比于对照组,研究组的治疗有效率更高(χ^(2)=6.6462,P=0.0099);相比于对照组,研究组治疗后的总胆红素(TBIL)、谷丙转氨酶(ALT)、白蛋白、凝血酶原时间(PT)、高迁移率族蛋白B1(HMGB1)、白细胞介素-1β(IL-1β)、单核细胞趋化蛋白-1(MCP-1)水平及MELD评分更低(P <0.05),而HBV-DNA水平则更高(P <0.05)。在不良反应方面,两组比较差异无统计学意义(P> 0.05)。结论 乙型肝炎早期肝衰竭患者在接受抗病毒药物治疗时,联合应用甲泼尼龙治疗能使临床疗效显著提高,不仅能改善肝功能,有效减轻炎性反应,而且不良反应并不会明显增加。 展开更多
关键词 乙型肝炎 肝衰竭 甲泼尼龙 抗病毒药物 肝功能 炎性因子
下载PDF
加味茵陈术附汤联合双重血浆分子吸附系统与血浆置换治疗慢加急性肝衰竭临床研究 被引量:4
17
作者 周琳 周晓玲 冯丽娟 《陕西中医》 CAS 2023年第2期170-173,共4页
目的:探讨加味茵陈术附汤联合双重血浆分子吸附系统(DPMAS)与血浆置换(PE)治疗慢加急性肝衰竭(ACLF)的临床疗效及安全性。方法:将66例ACLF患者根据治疗方案分为治疗组和对照组,每组33例。治疗组在常规治疗基础上采用中药加味茵陈术附汤... 目的:探讨加味茵陈术附汤联合双重血浆分子吸附系统(DPMAS)与血浆置换(PE)治疗慢加急性肝衰竭(ACLF)的临床疗效及安全性。方法:将66例ACLF患者根据治疗方案分为治疗组和对照组,每组33例。治疗组在常规治疗基础上采用中药加味茵陈术附汤联合DPMAS+PE治疗,对照组采用DPMAS+PE治疗,治疗两周,并随访8周。观察两组ACLF患者治疗后的症候积分、肝功能、凝血功能、并发症及生存率,评估加味茵陈术附汤联合DPMAS+PE治疗ACLF的临床疗效。结果:治疗组总有效率为75.75%,显著高于对照组42.42%(P<0.05);两组患者治疗后,中医症候积分、肝功能、凝血功能均较治疗前明显改善(P<0.05),且治疗组优于对照组(P<0.05)。统计两组并发症发生率,治疗组低于对照组,组间比较差异具有统计学意义(P<0.05);8周生存率比较,治疗组高于对照组,差异具有统计学意义(P<0.05)。结论:加味茵陈术附汤联合DPMAS+PE治疗ACLF,可以有效改善ACLF患者肝功能、凝血功能,并减轻临床症状,提高治疗有效率及生存率。 展开更多
关键词 肝功能衰竭 茵陈术附汤 血浆置换 双重血浆分子吸附系统 凝血功能
下载PDF
团体认知行为管理对肝衰竭患者焦虑水平、社会功能和生活质量的影响
18
作者 余雅奇 卢梅 +2 位作者 张曼 彭菁 王鲁文 《保健医学研究与实践》 2023年第S02期199-202,共4页
目的探讨团体认知行为管理对肝衰竭患者焦虑水平、社会功能和生活质量的影响。方法在2020年11月—2023年6月我院收治的肝衰竭患者中随机抽取104例,采用随机数字表法分为对照组(54例)与研究组(50例)。对照组患者采用常规护理干预,研究组... 目的探讨团体认知行为管理对肝衰竭患者焦虑水平、社会功能和生活质量的影响。方法在2020年11月—2023年6月我院收治的肝衰竭患者中随机抽取104例,采用随机数字表法分为对照组(54例)与研究组(50例)。对照组患者采用常规护理干预,研究组患者在对照组基础上采用团体认知行为管理。由专人采用汉密尔顿焦虑量表(HAMA)、领悟社会支持量表(PSSS)、慢性肝病问卷(CLDQ)调查2组患者干预前后的焦虑水平、社会功能和生活质量。结果干预前,2组患者HAMA、PSSS、CLDQ评分比较,差异无统计学意义(P>0.05)。干预后,2组患者HAMA评分均低于干预前且研究组低于对照组,PSSS及CLDQ各维度评分均高于干预前且研究组均高于对照组,差异均有统计学意义(P<0.05)。结论团队认知行为管理有助于减轻肝衰竭患者的焦虑情绪,提高患者社会功能,提升患者生活质量,值得在临床推广。 展开更多
关键词 团体认知行为管理 肝衰竭 焦虑水平 社会功能 生活质量
下载PDF
根治性肝切除术肝细胞癌患者预后预测模型研究进展
19
作者 张垚 赵成俊 +2 位作者 任宾 杜磊 马倩源 《协和医学杂志》 CSCD 2023年第6期1266-1273,共8页
Child-Pugh分级和终末期肝病模型是术前评估肝细胞癌(hepatocellular carcinoma, HCC)患者根治性肝切除术后肝功能衰竭及整体临床转归的经典方法,但受白蛋白、腹水、血肌酐等因素的影响,二者的应用存在一定局限性。查阅国内外相关文献... Child-Pugh分级和终末期肝病模型是术前评估肝细胞癌(hepatocellular carcinoma, HCC)患者根治性肝切除术后肝功能衰竭及整体临床转归的经典方法,但受白蛋白、腹水、血肌酐等因素的影响,二者的应用存在一定局限性。查阅国内外相关文献后发现,术前白蛋白-胆红素评分、血小板-白蛋白-胆红素评分、格拉斯哥预后评分以及新型预测模型在HCC患者肝切除术后肝功能衰竭及临床预后评估中具有良好的应用前景。本文将对常用的根治性肝切除术HCC患者预后模型进行介绍,并对其应用价值进行综述。 展开更多
关键词 肝细胞癌 肝切除术 肝功能评分 肝功能衰竭 预后模型
下载PDF
益生菌辅助治疗慢加急性肝衰竭后肠道菌群及预后观察
20
作者 程言明 田芝奥 李慧 《肝脏》 2023年第10期1208-1211,1226,共5页
目的分析慢加急性肝衰竭(ACLF)患者加用益生菌治疗后的预后情况。方法选取我院84例ACLF患者,随机均分为两组。对照组常规治疗,观察组予以常规^(+)肠道益生菌制剂治疗。观察治疗后患者菌群分布及生存情况。结果观察组治疗前乳酸杆菌、双... 目的分析慢加急性肝衰竭(ACLF)患者加用益生菌治疗后的预后情况。方法选取我院84例ACLF患者,随机均分为两组。对照组常规治疗,观察组予以常规^(+)肠道益生菌制剂治疗。观察治疗后患者菌群分布及生存情况。结果观察组治疗前乳酸杆菌、双歧杆菌数量(6.9±0.8)log_(10)nCFU/g、(5.5±0.9)log_(10)nCFU/g,大肠埃希菌、大肠杆菌数量(9.2±1.4)log_(10)nCFU/g、(8.8±0.4)log_(10)nCFU/g;治疗后乳酸杆菌、双歧杆菌数量分别为(8.4±0.6)log_(10)nCFU/g、(9.7±0.8)log_(10)nCFU/g,大肠埃希菌、大肠杆菌数量分别为(5.9±0.5)log_(10)nCFU/g、(6.1±0.4)log_(10)nCFU/g。对照组治疗前乳酸杆菌、双歧杆菌数量分别为(6.8±0.7)log_(10)nCFU/g、(5.4±0.8)log_(10)nCFU/g,大肠埃希菌、大肠杆菌数量分别为(9.0±1.3)log_(10)nCFU/g、(8.7±0.4)log_(10)nCFU/g;治疗后乳酸杆菌、双歧杆菌数量分别为(7.7±0.6)log_(10)nCFU/g、(7.6±0.8)log_(10)nCFU/g,大肠埃希菌、大肠杆菌数量分别为(6.8±0.5)log_(10)nCFU/g、(7.2±0.5)log_(10)nCFU/g。观察组治疗后乳酸、双歧杆菌数量更高,大肠杆菌、埃希菌则低于疗前和对照组(P<0.05)。观察组疗前CD4^(+)、IL-6、IL-10水平分别为(32.8±5.4)%、(87.1±11.2)pg/mL、(31.8±4.4)pg/mL;治疗后CD4^(+)、IL-6、IL-10水平分别为(44.7±2.4)%、(68.1±9.1)pg/mL、(20.5±3.4)pg/mL。对照组治疗前CD4^(+)、IL-6、IL-10水平分别为(34.2±5.6)%、(90.2±9.0)pg/mL、(32.0±4.0)pg/mL;治疗后CD4^(+)、IL-6、IL-10水平分别为(40.0±2.2)%、(75.4±10.2)pg/mL、(26.5±3.0)pg/mL。观察组治疗后CD4^(+)水平显著升高(P<0.05),IL-6、IL-10低于疗前及对照组(P<0.05)。观察组治疗前GGT、ALT、AST、TBil水平分别为(62.3±10.5)U/L、(83.4±11.8)U/L、(98.2±21.0)U/L、(318.6±23.6)μmol/L;治疗后GGT、ALT、AST、TBil水平分别为(49.2±11.0)U/L、(59.6±9.2)U/L、(45.2±9.1)U/L、(158.6±18.6)μmol/L。对照组治疗前GGT、ALT、AST、TBil水平分别为(62.0±11.1)U/L、(84.5±11.5)U/L、(97.5±21.5)U/L、(314.5±20.3)μmol/L;治疗后GGT、ALT、AST、TBil水平分别为(53.7±12.3)U/L、(62.5±10.9)U/L、(48.5±9.2)U/L、(162.8±20.3)μmol/L。上述指标治疗后均低于治疗前(P<0.05)。观察组1年累计生存率为83.33%(35/42),对照组1年累计生存率为78.57%(33/42),两组比较差异无统计学意义差异(P>0.05)。结论对ACLF患者应用益生菌,可抑制患者肠道致病菌生长,提升免疫及肝功能,并改善预后。 展开更多
关键词 益生菌 慢加急性肝衰竭 肠道菌群 预后 肝功能
下载PDF
上一页 1 2 12 下一页 到第
使用帮助 返回顶部